Related Experiment Videos
Pentoxifylline does not interfere with stable coumarin anticoagulant therapy: a clinical study
Pharmatherapeutica
|January 1, 1986
Summary
This study investigated pentoxifylline and coumarin interaction in patients. Results showed minimal impact on coagulation parameters, suggesting no significant clinical interaction during short-term use.
Area of Science:
- Pharmacology
- Hematology
- Clinical Medicine
Background:
- Pentoxifylline is a hemorheologic agent.
- Coumarin derivatives are widely used anticoagulants.
- Potential drug interactions between pentoxifylline and coumarin require investigation.
Purpose of the Study:
- To assess the potential interaction between pentoxifylline and coumarin.
- To evaluate the effect of pentoxifylline on coagulation parameters in patients on stable coumarin therapy.
Main Methods:
- Ten patients on stable coumarin treatment were studied.
- Pentoxifylline (1600 mg/day) was administered for 27 days.
- Coagulation parameters including bleeding time, platelet function, and clotting times were measured.
Main Results:
- Platelet aggregation showed slight increases in sensitivity to collagen in 2 patients.
- One patient exhibited a slight increase in spontaneous platelet aggregation.
- No significant changes were observed in other coagulation parameters.
Conclusions:
- Short-term co-administration of pentoxifylline with coumarin did not result in significant alterations in key coagulation markers.
- Further studies may be warranted to fully elucidate long-term interaction profiles.